ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
6,268.02
-0.01%
US Tech 100
22,382.80
0.60%
Dow Jones
44,200.31
-0.58%
Brent Oil
68.325
-0.40%
Bitcoin
116,335.98
-2.97%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Travere Therapeutics Inc (TVTX) Quote

Travere Therapeutics Inc

Travere Therapeutics Inc (TVTX)

NASDAQ
16.60
-0.31
( -1.83% )
Updated: 11:47:39
15 min delayed - Upgrade to Realtime

Travere Therapeutics Inc (TVTX) Quote

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
16.60
( -1.83% )
Bid
16.59
Ask
16.62
Volume
326,657
16.50 Day's Range 17.115
7.95 52 Week Range 25.29
Market Cap
1.474B
Previous Close
16.91
Open
17.05
Last Trade
100
@
16.5922
(average)
Last Trade Time
11:47:47
Financial Volume
$ 5,453,464
VWAP
16.6948
Average Volume (3m)
1,667,656
Shares Outstanding
88,804,818
Dividend Yield
-
PE Ratio
-4.58
Earnings Per Share (EPS)
-3.62
Revenue
233.18M
Net Profit
-321.55M

About Travere Therapeutics Inc

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
travere.com
Headquarters
Lewes, Delaware, USA
Founded
-
Travere Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TVTX. The last closing price for Travere Therapeutics was $16.91. Over the last year, Travere Therapeutics shares have traded in a share price range of $ 7.95 to $ 25.29.

Travere Therapeutics currently has 88,804,818 shares outstanding. The market capitalization of Travere Therapeutics is $1.50 billion. Travere Therapeutics has a price to earnings ratio (PE ratio) of -4.58.

Ask ADVFN Intelligence (AI)

TVTX Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
July 02 2025
TVTX (-1.83%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
June 17 2025
TVTX (-1.83%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.9113.002042205614.6917.3214.69150119116.30020238CS
42.0914.403859407314.5117.3213.88144083415.15666995CS
121.278.2844096542715.3322.0713.88166765616.8628137CS
26-0.94-5.3591790193817.5425.2912.9170845018.27728028CS
526.6967.5075681139.9125.297.95160011916.716147CS
156-7.79-31.939319393224.3929.145.12136697314.94505313CS
260-8.55-33.996023856925.1533.08995.12114895016.86322042CS

TVTX - Frequently Asked Questions (FAQ)

What is the current Travere Therapeutics share price?
The current share price of Travere Therapeutics is $ 16.60
How many Travere Therapeutics shares are in issue?
Travere Therapeutics has 88,804,818 shares in issue
What is the market cap of Travere Therapeutics?
The market capitalisation of Travere Therapeutics is USD 1.5B
What is the 1 year trading range for Travere Therapeutics share price?
Travere Therapeutics has traded in the range of $ 7.95 to $ 25.29 during the past year
What is the PE ratio of Travere Therapeutics?
The price to earnings ratio of Travere Therapeutics is -4.58
What is the cash to sales ratio of Travere Therapeutics?
The cash to sales ratio of Travere Therapeutics is 6.32
What is the reporting currency for Travere Therapeutics?
Travere Therapeutics reports financial results in USD
What is the latest annual turnover for Travere Therapeutics?
The latest annual turnover of Travere Therapeutics is USD 233.18M
What is the latest annual profit for Travere Therapeutics?
The latest annual profit of Travere Therapeutics is USD -321.55M
What is the registered address of Travere Therapeutics?
The registered address for Travere Therapeutics is 16192 COASTAL HWY, LEWES, DELAWARE, 19958
What is the Travere Therapeutics website address?
The website address for Travere Therapeutics is travere.com
Which industry sector does Travere Therapeutics operate in?
Travere Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CYCCCyclacel Pharmaceuticals Inc
$ 12.93
(290.63%)
26.99M
XAGELongevity Health Holdings Inc
$ 5.77
(118.15%)
87.88M
PLRZPolyrizon Ltd
$ 1.05
(53.94%)
99.24M
BLMZBloomZ Inc
$ 0.2155
(42.53%)
280.85M
IXHLIncannex Healthcare Ltd
$ 0.3305
(40.04%)
271.34M
SHOTWSafety Shot Inc
$ 0.0161
(-61.85%)
11.24k
RVYLRYVYL Inc
$ 0.3541
(-45.65%)
6.89M
RANIRani Therapeutics Holdings Inc
$ 0.4319
(-38.16%)
7.47M
WHLRLWheeler Real Estate Investment Trust Inc
$ 98.00
(-35.31%)
282
TROOTROOPS Inc
$ 0.89
(-33.58%)
2.81M
BLMZBloomZ Inc
$ 0.2155
(42.53%)
288.28M
IXHLIncannex Healthcare Ltd
$ 0.3305
(40.04%)
273.47M
NVDANVIDIA Corporation
$ 171.27
(4.39%)
136.24M
MULNMullen Automotive Inc
$ 0.113299
(-3.66%)
118.61M
OPENOpendoor Technologies Inc
$ 1.02
(13.23%)
100.33M

TVTX Discussion

View Posts
Monksdream Monksdream 2 months ago
TVTX under $25
👍️0
Monksdream Monksdream 4 months ago
TVTX under $25
👍️0
Monksdream Monksdream 10 months ago
TVTX under $15
👍️0
Monksdream Monksdream 1 year ago
TVTX under $10
👍️0
tw0122 tw0122 1 year ago
7.46 + 13% Looks good Caanacord $15 buy target. Once it breaks 9.83 on the way to $13. Probably take a few weeks and positive catalysts
👍️0
Monksdream Monksdream 1 year ago
TVTX under $10
👍️0
bikaver bikaver 2 years ago
TVTX.....In at 6.56
👍️0
bikaver bikaver 2 years ago
TVTX.....from 7.65 to 9.24 in 6 days
👍️0
bikaver bikaver 2 years ago
TVTX.....Gambling on a dead cat bounce.....in @ 7.65 AH.
👍️0
Stockexpertpro Stockexpertpro 2 years ago
Watching for the Collapse under 8$ This could get ugly today 7$ probably under 6$ Coming
👍️0
alchemytrader alchemytrader 4 years ago
Arent they all modern day drug dealers?
👍️0
cash4 cash4 4 years ago
Free Martin Shkreli, LMFAO, felon CEO with a 1,5 billion company trading at $32 PPS, you gotta love America, just another modern day Drug Dealer.
👍️0

Your Recent History

NASDAQ
TVTX
Travere Therapeutics
Delayed Upgrade Clock
ADVFN
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads